(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

G GENINVO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

G GENINVO

ST13

US500000099342996

Class

35, 42

Filing

99342996

Registration

8193279

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

03/31/2026

Trademark type

Combined

Nice classes

35, 42

Filing date

08/18/2025

Registration date

03/31/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/31/2026

Last transaction

03/31/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

2019-07-00

First use in commerce

2019-07-00

Drawing code

3

Owner type

03

Owner location

Bloomington, IL, US

Examiner

CLARK, ANDREW T

Law office

L70

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of two concentric circles. Inside the center circle is the stylized letter "G" above the word "GENINVO." Above the leg of the letter "G" is a round shape made up of three concentric circles. To the right of the stem of the letter G is a horizontal chevron shape. The word "GENINVO" below the letter "G" has a dot on top of the letter "I".

Holders and representatives

Holders

GenInvo, Inc.

Representatives

Matthew Saunders Saunders & Silverstein LLP

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consulting services for pharmaceutical and life sciences companies in the fields of clinical researchclinical trialsapplications for drug approval; Business data analytics and business data management services in the pharmaceutical and life sciences fields of clinical research; Business consulting and management in the field of clinical trialsclinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; Providing independent review of clinical trial data for business purposes

Class 42

Providing temporary use of online non-downloadable software and software applications for data management and data analysis in the nature of clinical trial data ingestiondata anonymizationdata collaborationdata transformationpredictive data analysisdocument reviewmetadata managementpatient data anonymizationautomated reporting; providing temporary use of online non-downloadable software and software applications using artificial intelligence (AI) for data management and data analysis in the nature of clinical trial data ingestiondata anonymizationdata collaborationdata transformationpredictive data analysisdocument reviewmetadata managementpatient data anonymizationautomated reporting; Custom design of computer application software; Technical support servicescloud managed services in the nature of remote infrastructure management services for migrationconfigurationmonitoringmanagement of cloud computing IT systems and cloud databases; Providing quality control services in the fields of clinical researchclinical trialsapplications for drug approval; Providing independent review of clinical trial data for medical or scientific purposes

Publications

History of USPTO decisions and trademark events.

15 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/31/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/31/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/10/2026

PUBO

PUBLISHED FOR OPPOSITION

02/10/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/04/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/13/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

01/13/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/13/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

01/13/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/13/2026

DOCK

ASSIGNED TO EXAMINER

01/05/2026

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/05/2026

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/05/2026

MAFR

APPLICATION FILING RECEIPT MAILED

08/18/2025

NWAP

NEW APPLICATION ENTERED

08/18/2025

Continuous trademark protection

Get notified about every new filing that threatens G GENINVO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.